共 142 条
[1]
Ziaeian B(2016)Epidemiology and aetiology of Heart Failure Nat Reviews Cardiol 13 368-78
[2]
Fonarow GC(2016)Modeling future Cardiovascular Disease mortality in the United States: national trends and racial and ethnic disparities Circulation 133 967-78
[3]
Pearson-Stuttard J(2016)Medical resource use and expenditure in patients with chronic Heart Failure: a population‐based analysis of 88 195 patients Eur J Heart Fail 18 1132-40
[4]
Guzman-Castillo M(2022)Effectiveness of telemedicine visits in reducing 30-day readmissions among patients with Heart Failure during the COVID‐19 pandemic J Am Heart Association 11 e023935-23
[5]
Penalvo JL(2020)Acute Heart Failure Nat Reviews Disease Primers 6 16-87
[6]
Rehm CD(2018)A review of the role of the pharmacist in Heart Failure transition of care Adv Therapy 35 311-70
[7]
Afshin A(2019)Updates in Heart Failure 30-day readmission prevention Heart Fail Rev 24 177-62
[8]
Danaei G(2023)All-cause unplanned readmissions in the United States: insights from the Nationwide Readmission Database Intern Med J 53 262-97
[9]
Farré N(2020)Management of Heart Failure and type 2 Diabetes Mellitus: maximizing complementary drug therapy Diabetes Obes Metabolism 22 1243-27
[10]
Vela E(2019)Angiotensin receptor blockers versus angiotensin converting enzyme inhibitors for the treatment of arterial Hypertension and the role of olmesartan Adv Therapy 36 278-44